Tarsus Pharmaceuticals reported revenue of $173.91M and net income of -$18.81M for the quarter ended Jun 2026, up 69.4% year over year. This income statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||
| Revenue | 1.24M | 0.34M | 0.54M | 15.28M | 10.00M | 2.50M | 1.87M | 13.08M | 27.61M | 40.81M | 48.12M | 66.41M | 78.33M | 102.66M | 118.70M | 151.67M | 162.05M | 173.91M | ||||||||||
| Cost of RevenueCost of Rev | 0.07M | -0.02M | 0.03M | 0.52M | 0.40M | 0.38M | 1.22M | 1.65M | 3.00M | 3.24M | 4.93M | 5.21M | 6.24M | 8.31M | 10.93M | 9.40M | 12.11M | |||||||||||
| Gross Profit | 1.18M | 0.36M | 0.51M | 14.76M | 9.60M | 2.50M | 1.49M | 11.86M | 25.96M | 37.81M | 44.88M | 61.48M | 73.12M | 96.42M | 110.39M | 140.74M | 152.66M | 161.80M | ||||||||||
| Operating items | ||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 10.21M | 8.04M | 12.08M | 9.60M | 10.91M | 0.50M | 12.36M | 12.55M | 12.11M | 13.30M | 12.07M | 12.32M | 12.13M | 16.87M | 14.41M | 15.59M | 16.28M | 18.04M | 22.35M | 31.01M | ||||||||
| Selling, General & AdministrativeSG&A | 6.67M | 6.77M | 7.95M | 10.38M | 11.99M | 14.63M | 15.10M | 20.27M | 30.32M | 43.01M | 51.58M | 58.79M | 57.91M | 69.03M | 85.00M | 103.01M | 108.63M | 130.68M | 136.43M | 150.70M | ||||||||
| Other Operating ExpensesOther Opex | 0.07M | -0.02M | 0.03M | 0.52M | 9.93M | 0.38M | 1.22M | 1.65M | 3.00M | 3.24M | 4.93M | 5.21M | 6.24M | 8.31M | 10.93M | 9.40M | 12.11M | |||||||||||
| Operating ExpensesOpex | 16.95M | 14.79M | 20.06M | 20.50M | 22.91M | 25.06M | 27.45M | 32.82M | 42.81M | 57.53M | 65.30M | 74.11M | 73.28M | 90.83M | 104.61M | 124.84M | 133.23M | 159.64M | 168.18M | 193.82M | ||||||||
| Operating IncomeOp. Inc | -15.71M | -14.45M | -19.52M | -5.22M | -22.91M | -15.06M | -24.95M | -32.82M | -40.94M | -44.45M | -37.68M | -33.30M | -25.16M | -24.42M | -26.28M | -22.18M | -14.53M | -7.98M | -6.12M | -19.91M | ||||||||
| EBIT | -15.71M | -14.45M | -19.52M | -5.22M | -22.91M | -15.06M | -24.95M | -32.82M | -40.94M | -44.45M | -37.68M | -33.30M | -25.16M | -24.42M | -26.28M | -22.18M | -14.53M | -7.98M | -6.12M | -19.91M | ||||||||
| Non-operating items | ||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.32M | 0.54M | 0.63M | 0.69M | 0.68M | 0.81M | 0.86M | 0.99M | 0.98M | 2.11M | 2.44M | 2.31M | 2.21M | 2.24M | 2.27M | 2.21M | 2.13M | 2.16M | ||||||||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | 0.01M | -0.11M | 0.42M | -0.01M | 2.81M | |||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.01M | 0.01M | 0.30M | 1.06M | 2.13M | 2.29M | 2.23M | 2.84M | 2.98M | 3.12M | 4.13M | 4.12M | 3.65M | 3.45M | 4.23M | 4.11M | 3.95M | 3.72M | 3.70M | |||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.35M | 0.23M | -0.24M | -0.26M | -0.02M | 0.02M | -0.02M | -0.05M | -0.05M | 0.36M | -0.18M | -1.94M | 0.07M | -0.08M | -0.14M | 0.10M | -0.07M | -0.09M | -0.28M | |||||||||
| Non Operating IncomeNon Op. Inc. | -0.33M | -0.35M | -0.72M | -0.52M | 0.39M | 1.46M | 1.53M | 1.40M | 1.79M | 2.55M | 1.95M | 0.01M | 1.74M | 1.31M | 1.16M | 1.84M | 1.94M | 1.66M | 1.51M | 4.07M | ||||||||
| Net income details | ||||||||||||||||||||||||||||
| EBT | -15.70M | -14.44M | -19.84M | -5.47M | -22.48M | -13.63M | -23.34M | -31.41M | -38.95M | -42.46M | -35.55M | -31.28M | -23.49M | -23.09M | -25.04M | -20.20M | -12.68M | -6.24M | -4.53M | -18.37M | ||||||||
| Tax ProvisionsTaxes | -0.34M | 0.05M | 0.00M | -0.01M | 2.40M | 2.72M | ||||||||||||||||||||||
| Profit After TaxPAT | -15.70M | -14.85M | -20.24M | -5.74M | -22.52M | -13.66M | -23.42M | -31.42M | -39.15M | -41.90M | -35.73M | -33.29M | -23.42M | -23.11M | -25.12M | -20.39M | -12.59M | -8.37M | -6.97M | -18.81M | ||||||||
| Income from Continuing OperationsIncome (Continuing) | -15.36M | -14.49M | -19.84M | -5.47M | -22.47M | -13.63M | -23.34M | -31.41M | -38.95M | -42.46M | -35.55M | -31.28M | -23.49M | -23.09M | -25.04M | -20.20M | -12.68M | -6.24M | -6.93M | -21.08M | ||||||||
| Consolidated Net IncomeConsol Net Inc. | -15.36M | -14.49M | -19.84M | -5.47M | -22.47M | -13.63M | -23.34M | -31.41M | -38.95M | -42.46M | -35.55M | -31.28M | -23.49M | -23.09M | -25.04M | -20.20M | -12.68M | -6.24M | -6.93M | -21.08M | ||||||||
| Income towards Parent CompanyParent Net Inc | -15.36M | -14.49M | -19.84M | -5.47M | -22.47M | -13.63M | -23.34M | -31.41M | -38.95M | -42.46M | -35.55M | -31.28M | -23.49M | -23.09M | -25.04M | -20.20M | -12.68M | -6.24M | -6.93M | -21.08M | ||||||||
| Net Income towards Common StockholdersNet Income | -15.36M | -14.49M | -19.84M | -5.47M | -22.47M | -13.63M | -23.34M | -31.41M | -38.95M | -42.46M | -35.55M | -31.28M | -23.49M | -23.09M | -25.04M | -20.20M | -12.68M | -6.24M | -6.93M | -21.08M | ||||||||
| Additional items | ||||||||||||||||||||||||||||
| EPS (Basic) | -0.74 | -0.70 | -0.96 | -0.22 | -0.84 | -0.55 | -0.87 | -1.17 | -1.27 | -1.45 | -1.01 | -0.83 | -0.61 | -0.61 | -0.64 | -0.48 | -0.30 | -0.15 | -0.16 | -0.49 | ||||||||
| EPS (Diluted) | -0.74 | -0.70 | -0.96 | -0.22 | -0.84 | -0.55 | -0.87 | -1.17 | -1.27 | -1.45 | -1.01 | -0.83 | -0.61 | -0.61 | -0.64 | -0.48 | -0.30 | -0.15 | -0.16 | -0.49 | ||||||||
| Shares Outstanding | 20.64M | 20.55M | 20.71M | 24.33M | 26.66M | 24.62M | 26.74M | 26.82M | 30.62M | 29.38M | 35.30M | 37.82M | 38.38M | 37.60M | 39.35M | 42.36M | 42.61M | 41.78M | 42.96M | 43.39M | ||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 20.64M | 20.55M | 20.71M | 24.33M | 26.66M | 24.62M | 26.74M | 26.82M | 30.62M | 29.38M | 35.30M | 37.82M | 38.38M | 37.60M | 39.35M | 42.36M | 42.61M | 41.78M | 42.96M | 43.39M | ||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 20.70M | 20.70M | 20.72M | 26.64M | 26.70M | 26.73M | 26.80M | 26.90M | 33.10M | 34.21M | 37.75M | 38.03M | 38.20M | 38.35M | 42.00M | 42.21M | 42.45M | 42.55M | 43.02M | 43.27M | ||||||||
| EBITDA | -15.71M | -14.45M | -19.52M | -5.22M | -22.91M | -15.06M | -24.95M | -32.82M | -40.94M | -44.45M | -37.68M | -33.30M | -25.16M | -24.42M | -26.28M | -22.18M | -14.53M | -7.98M | -6.12M | -19.91M | ||||||||
| Interest ExpensesInt Expense | 0.32M | 0.54M | 0.63M | 0.69M | 0.68M | 0.81M | 0.86M | 0.99M | 0.98M | 2.11M | 2.44M | 2.31M | 2.21M | 2.24M | 2.27M | 2.21M | 2.13M | 2.16M | ||||||||||
| Tax Rate | 2.17% | -0.37% | -0.01% | 0.02% | -53.00% | -14.79% |